Re-use of equipment between patients receiving total intravenous anaesthesia: A postal survey of current practice

Anaesthesia

Volumn 58, Issue 6, 2003, Pages 582-587

  Halkes, M J ^a   Snow, D ^a  

^a TORBAY HOSPITAL   (United Kingdom)

Author keywords

Anaesthetics; Complications; infections; Equipment; infusion systems; Intravenous; propofol

Indexed keywords

INTRAVENOUS ANESTHETIC AGENT; PROPOFOL;

ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COMPARATIVE STUDY; CONSULTATION; CONTROLLED STUDY; COST CONTROL; EVIDENCE BASED MEDICINE; GENERAL HOSPITAL; HEALTH CARE COST; HEALTH SURVEY; INFUSION SYSTEM; INTRAVENOUS ANESTHESIA; LEGAL LIABILITY; MEDICAL PRACTICE; MEDICAL SOCIETY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; RECYCLING; RISK BENEFIT ANALYSIS; STANDARDIZATION; VALVE; WASTE DISPOSAL;

ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; CLINICAL COMPETENCE; CROSS INFECTION; EQUIPMENT REUSE; GREAT BRITAIN; HEALTH CARE SURVEYS; HUMANS; INFUSIONS, INTRAVENOUS; PRACTICE GUIDELINES; PROFESSIONAL PRACTICE; PROPOFOL; QUESTIONNAIRES;

EID: 0037528690     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2003.03181.x     Document Type: Article

References (15)

1. Sung YF, Reiss N, Tillette T. The differential cost of anaesthesia and recovery with propofol-nitrous oxide anaesthesia versus thiopental sodium-isoflurane-nitrous oxide anaesthesia. Journal of Clinical Anaesthesiology 1991; 3: 391-4.
2. Bach A, Motsch J. Influence risks associated with the use of propofol. Acta Anaesthesiologica Scandinavica 1996; 40: 1189-96.
3. Kuehnert MJ, Webb PM, Jochimsen EM et al. Staphylococcus aureus bloodstream infections amongst patients undergoing electroconvulsive therapy traced to breaks of infection control and possible extrinsic contamination of propofol. Anesthesia and Analgesia 1997; 85: 420-5.
4. Bennett SN, McNeil MM, Bland LA et al. Postoperative infections traced to contamination of an intravenous anaesthetic, propofol. New England Journal of Medicine 1995; 333: 147-54.
5. McNeil MM, Lasket BA, Lott TJ, Jarvis WR. Post surgical Candida albicans infection associated with the extrinsic contamination of an intravenous anaesthetic agent. Journal of Clinical Microbiology 1999; 37: 1398-403.
6. Villarino ME, McNeil MM, Hall WN et al. Post surgical infections associated with an extrinsically contaminated intravenous anaesthetic agent. Interscience Conference on Anti-Microbiol Agents and Chemotherapy. Program and Abstracts, 1991, 156: Abstract 46.
7. Nichols RL, Smith JW. Bacterial contamination of an anaesthetic agent. New England Journal of Medicine 1995; 333: 184-5.
8. Kempen PM, Learned DW. Anaesthesia practice - A vector for infection? Anesthesiology 1989; 71: A948.
9. Bach A. Spritzen-oder Leitungswechsel bei TCI? Anaesthetist 1998; 47: 434-6.
10. Trepanier CA, Lessard MR, Brochu JG, Denault PH. Risk of cross infection related to the multiple use of disposable syringes. Canadian Journal of Anaesthesia 1990; 37: 156-9.
11. Crosby E. Intravenous infusions and one way valves. Canadian Journal of Anaesthesia 1991; 38: 799-800.
12. Medical Devices Agency. Single-use medical devices: Implications and consequences of re-use. Medical Agency Device Bulletin 2000; 4: 1-19.
13. Swygert T, Donica S, Ramsay M. Hazards of re-using disposable syringes: I. Anesthesiology 1991; 74: 790.
14. Sherry E. Hazards of re-using disposable syringes: II. Anesthesiology 1991; 74: 790.
15. Rowe WL. Economics and anaesthesia. Anaesthesia 1998; 53: 782-8.